Oasmia Pharmaceutical AB
Publication of change in the total number of shares and votes in Oasmia
Oasmia Pharmaceutical AB 30.12.2014 08:49 Dissemination of a Adhoc News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Uppsala, Sweden, 2014-12-30 08:49 CET (GLOBE NEWSWIRE) -- The total number of shares and votes in Oasmia Pharmaceutical AB (publ) amounts to 97,858,144 as of December 30, 2014. The increase in the number of shares is attributable to the new share issue with preferential rights for current shareholders carried out in November/December 2014, which comprised 9,785,814 shares. The share issue was registered in its entirety with the Swedish Companies Registration Office on December 15, 2014. A list of the company principal shareholders will be available at www.oasmia.com About Oasmia Pharmaceutical AB Oasmia Pharmaceutical AB develops a new generation of drugs within human and veterinary oncology. The product development aims to manufacture novel formulations based on well-established cytostatics which, compared to current alternatives, show improved properties, a reduced side-effect profile and an expanded therapeutic area. Product development is based on in-house research within nanotechnology and proprietary patents. Oasmia Pharmaceutical AB's shares, ISIN SE0000722365, are listed on NASDAQ Stockholm (OASM) and the Frankfurt Stock Exchange (OMAX). Anders Lundin, CFO Mobile: +46 70 209 63 00 E-mail: anders.lundin@oasmia.com News Source: NASDAQ OMX 30.12.2014 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: Oasmia Pharmaceutical AB Sweden Phone: Fax: E-mail: Internet: ISIN: SE0000722365 WKN: End of Announcement DGAP News-Service ---------------------------------------------------------------------------
Aktuelle News
Aktuelle Berichte
Keine Berichte gefunden
Anstehende Events
Keine Events gefunden
Webcasts
Keine Webcasts gefunden